MAIA Biotechnology reported cash from operations of -$6.75M and free cash flow of -$6.75M for the quarter ended Jun 2026, down 63.2% year over year. This cash flow statement covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||
| Net Income | -2.68M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.19M | -4.67M | -4.95M | -6.35M | -3.90M | -3.73M | -4.08M | -4.92M | -5.34M | -5.09M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Share-based CompensationStock Comp. | 0.78M | 0.61M | 0.71M | 5.93M | 6.51M | 0.49M | 7.22M | 7.78M | 7.86M | 1.36M | 8.06M | 9.32M | 9.39M | 0.69M | 10.90M | 11.95M | 12.13M | 0.81M | 13.10M | 16.68M | |
| Gains from Investment SecuritiesGains Investment | 0.10M | -0.13M | 0.03M | -0.02M | -0.10M | -0.02M | -0.06M | 4.18M | 5.16M | -1.33M | -1.32M | -0.83M | 0.26M | -0.38M | -0.25M | -0.25M | 0.07M | ||||
| Cash from OperationsCash from Ops. | -1.31M | -1.61M | -2.81M | -2.02M | -4.32M | -2.95M | -3.36M | -2.56M | -3.16M | -3.99M | -3.59M | -4.68M | -3.52M | -3.91M | -4.20M | -4.14M | -3.49M | -7.02M | -5.31M | -6.75M | |
| Depreciation, Depletion & Amortization | |||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.33M | -1.00 | |||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.07M | 0.04M | 0.05M | 0.04M | -0.27M | 0.02M | |||||||||||||||
| Change in Account PayablesChange Payables | 0.26M | 0.46M | -0.07M | 0.16M | -0.03M | 0.15M | -0.04M | 0.42M | -0.32M | 0.41M | 0.24M | -0.61M | -0.12M | 0.37M | 0.36M | -0.15M | 1.45M | -1.14M | 0.94M | -0.14M | |
| Change in Accured ExpensesChange Accured Exp. | 0.25M | 0.65M | 0.35M | 0.52M | -0.62M | 0.66M | 0.01M | 0.59M | 1.20M | 0.37M | -0.28M | -0.77M | 0.21M | -0.14M | 0.87M | 0.13M | 3.50M | -3.02M | -0.46M | 0.08M | |
| Financing Activities | |||||||||||||||||||||
| Other financing activitiesOther financing | 0.52M | 0.11M | 0.28M | 11.11M | 0.20M | 0.01M | 0.66M | 0.10M | 0.05M | 0.12M | 6.45M | 0.10M | 33.01M | ||||||||
| Cash from Financing ActivitiesCash from Financing | 5.48M | 1.23M | 2.53M | -0.12M | 10.26M | -0.19M | 0.13M | 5.03M | 4.72M | 7.99M | 0.63M | 4.85M | 5.46M | 3.41M | 4.23M | 4.80M | 31.05M | -0.07M | |||
| Change in Capital Stock | |||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.81M | 0.67M | 1.61M | 0.98M | 3.04M | 1.14M | 4.02M | 0.64M | |||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.38M | 2.37M | 0.10M | 2.92M | 4.94M | 0.66M | 3.11M | 1.52M | 1.48M | ||||||||||||
| Additional items | |||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.00M | -0.00M | -0.03M | 0.03M | -0.00M | 954.00 | -0.01M | 0.01M | -0.01M | 0.01M | -0.00M | -0.02M | 0.00M | 0.01M | -0.00M | -0.02M | 0.01M | -0.00M | |||
| Change in Cash | 4.17M | -0.38M | -0.28M | -2.14M | 5.91M | -3.11M | -3.36M | 1.56M | -3.04M | 1.05M | 1.12M | 3.31M | -2.89M | 0.91M | 1.26M | -0.72M | 0.75M | -2.23M | 25.76M | -6.82M | |
| Free Cash FlowFCF | -1.31M | -1.61M | -2.81M | -2.02M | -4.32M | -2.95M | -3.36M | -2.56M | -3.16M | -3.99M | -3.59M | -4.68M | -3.52M | -3.91M | -4.20M | -4.14M | -3.49M | -7.02M | -5.31M | -6.75M | |
| Net Cash FlowNCF | 4.17M | -0.38M | -0.28M | -2.14M | 5.94M | -3.14M | -3.36M | -2.56M | -3.03M | 1.03M | 1.13M | 3.30M | -2.90M | 0.94M | 1.26M | -0.73M | 0.75M | -2.22M | 25.74M | -6.82M |